Us TOO launches campaign for PCa awareness month
In conjunction with September as prostate cancer awareness month, Us TOO International is launching its nationwide “SEA Blue” campaign on behalf of prostate cancer patients and their families.
In conjunction with September as prostate cancer awareness month, Us TOO International is launching its nationwide “SEA Blue” campaign on behalf of prostate cancer patients and their families.
“The SEA [support, education, and advocacy] Blue campaign is designed to reach out to those at risk, promote prostate cancer screening, and give a voice in the community to the issue of prostate cancer awareness,” said Thomas Kirk of Us TOO.
“Prostate cancer actually strikes more men than breast cancer does women each year, yet the public remains largely unaware of this serious health issue and the significance of the blue ribbon. We think it’s important, in recognition of prostate cancer awareness month, for everyone to ‘see blue’ and realize that, as pink is to breast cancer, blue is to prostate cancer.”
Us TOO’s “SEA Blue” campaign is being supported by informational materials, lapel pins, window stickers, and posters that the organization is distributing to its more than 300 local chapters around the country.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
